Zydus Lifesciences Share Price

Zydus Lifesci.

CMP as on16-May-22 14:00

₹ 345.50
4.8 1.41%

Open

₹ 341.00

Turnover (lac)

₹ 419

Prev. Close

₹ 340.70

Day's Vol (shares)

₹ 40,106

Day's Range

₹ 337.20
₹ 347.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 25-Jan-2022 - -
CADILA HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2022 inter alia to consider and approve Approval of the unaudited financial results for the quarter / nine months ended on December 31 2021 The unaudited financial results (standalone and consolidated) for the quarter / nine months ended on December 31, 2021 (As Per BSE Announcement dated on 03.02.2022)
Board Meeting - 21-Jan-2022 - -
Re-appointment of Dr. Sharvil P. Patel as the Managing Director subject to approval of shareholders.
Board Meeting - 20-Oct-2021 - -
Quarterly Results Unaudited Financial Results for the quarter / half year ended on September 30, 2021 (As Per BSE Announcement dated on 29.10.2021)
Board Meeting - 03-Aug-2021 - -
CADILA HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2021 ,inter alia, to consider and approve June 2021 unaudited financial results Intimation of unaudited results for the quarter ended on June 30, 2021. (As Per BSE Announcement Dated on 11.08.2021)
Board Meeting - 09-Jul-2021 - -
Re-appointment of Mr. Ganesh N. Nayak as the Executive Director of the Company for a period of three years, subject to approval of shareholders at the ensuing AGM.
Board Meeting - 21-May-2021 - -
CADILA HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2021 ,inter alia, to consider and approve Audited Financial Results for the year ended on March 31, 2021 and recommendation of final dividend for the financial year 2020-2021. Outcome of Board Meeting Audited Financial Results for the year ended March 31, 2021 Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2021, inter alia, have recommended final dividend of Rs. 3.50/- (@ 350%) per equity share of Re. 1/- each, subject to approval of the shareholders at the ensuing Annual General Meeting scheduled to be held on August 11, 2021. (As Per BSE Announcement Dated 27.05.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity